Publications dans lesquelles il/elle collabore avec María José Sánchez Pérez (12)

2022

  1. Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study

    Medicine (United States), Vol. 101, Núm. 42, pp. E31175

2021

  1. Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study

    Medicine (United States), Vol. 100, Núm. 47

  2. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

    Journal of Biomedical Science, Vol. 28, Núm. 1

  3. Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study

    BMC Infectious Diseases, Vol. 21, Núm. 1

2019

  1. Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study

    BMC research notes, Vol. 10, Núm. 1, pp. 708

2015

  1. Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: A multicentre observational study

    BMC Urology, Vol. 15, Núm. 1

  2. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

  3. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

  4. Quality of life in patients with non-muscle-invasive bladder cancer: One-year results of a multicentre prospective cohort study

    Urologic Oncology: Seminars and Original Investigations, Vol. 33, Núm. 1, pp. 19.e7-19.e15

2014

  1. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

2011

  1. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849